Fig. 8From: Dramatic radiotherapy response of a giant T4 cutaneous squamous cell carcinoma of the scalp with extensive bone destruction: a case reportClinical appearance at 10 months follow-up during PD-1 inhibiting antibody therapy with cemiplimab. The patient presented with a good cosmetic result without evidence of tumor recurrence. He had no late complications after radiotherapy. Treatment with cemiplimab was well tolerated without adverse events.Back to article page